Renaissance Capital logo

Chinese healthcare data company LinkDoc Technology files for a $100 million US IPO

June 14, 2021
LDOC

LinkDoc Technology, a Chinese healthcare data company specializing in oncology patients, filed on Monday with the SEC to raise up to $100 million in an initial public offering.

LinkDoc Technology provides a data-driven and AI-enabled healthcare technology platform that structures cancer patient data to enable precision medicine and personalized care. The company's platform consist of LinkCare, a digital continuous care platform for patients with critical diseases, LinkData, an AI-enabled curation system for longitudinal medical data, and LinkSolutions, a data-driven precision life sciences platform that helps accelerate clinical research. Since 2015, LinkDoc's platform has cumulatively cared for over 3.5 million patients and provided longitudinal care for over 2.5 million patients. 

The Beijing, China-based company was founded in 2014 and booked $157 million in sales for the 12 months ended March 31, 2021. It plans to list on the Nasdaq under the symbol LDOC. Morgan Stanley, BofA Securities, and CICC are the joint bookrunners on the deal. No pricing terms were disclosed.